Multiple Myeloma External Comparator Cohort
Real-world data (RWD) in Oncology proves to be a vital source for clinical decisions and program decisions. COTA partnered with a Top 5 Pharma company to curate a custom multiple myeloma real-world cohort for use as a synthetic control arm regulatory filing.
